Skip to main content

. 1994 Aug;57(8):1013–1014. doi: 10.1136/jnnp.57.8.1013

Persistent hemiballism in Parkinson's disease.

R Inzelberg, A D Korczyn

PMCID: PMC1073103 PMID: 7605411

1013

Images in this article

Image
on p.1013

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Aziz T. Z., Peggs D., Sambrook M. A., Crossman A. R. Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate. Mov Disord. 1991;6(4):288–292. doi: 10.1002/mds.870060404. [DOI] [PubMed] [Google Scholar]
Mitchell I. J., Clarke C. E., Boyce S., Robertson R. G., Peggs D., Sambrook M. A., Crossman A. R. Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience. 1989;32(1):213–226. doi: 10.1016/0306-4522(89)90120-6. [DOI] [PubMed] [Google Scholar]
Sellal F., Hirsch E., Lisovoski F., Mutschler V., Collard M., Marescaux C. Contralateral disappearance of parkinsonian signs after subthalamic hematoma. Neurology. 1992 Jan;42(1):255–256. doi: 10.1212/wnl.42.1.255. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES